Hacioglu, M. B. Et Al. 2020. Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey. JOURNAL OF BUON , vol.25, no.4 , 1897-1903.

Hacioglu, M. B., Kostek, O., Karabulut, S., Tastekin, D., SEZGİN GÖKSU, S., Alandag, C., ... Akagunduz, B.(2020). Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey. JOURNAL OF BUON , vol.25, no.4, 1897-1903.

Hacioglu, Muhammet Et Al. "Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey," JOURNAL OF BUON , vol.25, no.4, 1897-1903, 2020

Hacioglu, Muhammet B. Et Al. "Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey." JOURNAL OF BUON , vol.25, no.4, pp.1897-1903, 2020

Hacioglu, M. B. Et Al. (2020) . "Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey." JOURNAL OF BUON , vol.25, no.4, pp.1897-1903.

@article{article, author={Muhammet Bekir Hacioglu Et Al. }, title={Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey}, journal={JOURNAL OF BUON}, year=2020, pages={1897-1903} }